http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112852981-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24ae3ff27b64d8d6516ec5127c1ac829 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate | 2019-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01f74a067efd009458a101b33844e6ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14871b08182ee466ebf87b8ee47c5761 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8de15031eed0b5e129ef850718d3be8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d417dacc13a7606d36602fec7947f671 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7608719a40e724c0229052044a704074 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aa06b8ba5fb020f4d3f15edd001e18b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e04fd8b6810e0b61057be39bccf66d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c292cc3c51b666cea7d6d648f059375 |
| publicationDate | 2021-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112852981-A |
| titleOfInvention | Intestinal microbial marker of abdominal aortic aneurysm and application thereof |
| abstract | The invention relates to an intestinal microbial marker of abdominal aortic aneurysm and application thereof. The invention determines 30 intestinal microbial markers of abdominal aortic aneurysm based on a classifier modeling evaluation and verification method of intestinal microbial abundance, wherein 25 intestinal microbial markers are up-regulated and 5 intestinal microbial markers are down-regulated, and high-risk groups of abdominal aortic aneurysm can be effectively screened or early patients can be found according to the intestinal microbial markers of abdominal aortic aneurysm, so that the abdominal aortic aneurysm can be prevented from further expanding and the rupture risk can be reduced as soon as possible, and the treatment effect of the abdominal aortic aneurysm can be monitored. Meanwhile, the intestinal microbial marker can be used for preparing a diagnostic kit and a therapeutic drug. The invention overcomes the defects that the existing abdominal aortic aneurysm diagnosis can not realize early screening and can not predict the onset and development trend of the abdominal aortic aneurysm, and the like, and can help disease pathological typing, medicine action target point research, accurate medication, pathogenesis research and the like. |
| priorityDate | 2019-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.